| 标题 |
Cost-Effectiveness of olaparib plus bevacizumab versus bevacizumab monotherapy as first-line maintenance for patients with advanced ovarian cancer: a analysis from a Chinese healthcare perspective |
| 网址 | |
| DOI | |
| 其它 |
期刊:Daru 作者:Cai P, Liu J, Yu C, Chen Q, Huang S, Zeng L, Sun Y, Huang A 出版日期:2026-07-22 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)